Dossier
weight loss drug maker
Coverage of weight loss drug maker in the Nexus archive.
- Weight loss drug maker sinks 25% after new safety data spooks investors
A weight loss drug maker's stock declined 25% after new safety data raised concerns among investors. The experimental drug met its key targets, but analysts are worried about its commercial potential due to side effects.